News Releases

by Year

2006

  • Dec. 13, 2006 (PDF/60KB)R&D
    Review of overseas development of Lurasidone (SM-13496), an atypical antipsychotic
  • Nov. 28, 2006 (PDF/106KB)R&D
    Revising domestic development plan of AC-5216, an antianxiety/antidepressant agent
  • Nov. 24, 2006 (PDF/71KB)Related Business
    Notice of Diagnostics Business Merger
  • Nov. 08, 2006 (PDF/208KB)Finances
    Summary of Interim Consolidated Financial Results For The Year Ending March 31, 2007
  • Nov. 08, 2006 (PDF/791KB)Finances
    Supplementary of Interim Consolidated Financial Data For The Year Ending March 31, 2007
  • Oct. 27, 2006 (PDF/113KB)Finances
    Revised March 2007 Interim and Fiscal-Year Financial Estimates
  • Aug. 21, 2006 (PDF/52KB)Corporate
    Dainippon Sumitomo Pharma and Sumitomo Chemical agree with Pfizer on Settlement of Amlodin Lawsuit
  • Aug. 03, 2006 (PDF/29KB)Products
    Conclusion of an Agreement over Co-promotion of Dops for the Treatment of Orthostatic Hypotension
  • Jul. 28, 2006 (PDF/830KB)Finances
    Overview of Consolidated Financial Results for the First Quarter of the Year Ending March 31, 2007
  • Jul. 24, 2006 (PDF/57KB)Licensing
    Partnership Agreements Concerning Anti-Hypertension & Hepatocellular Cancer Drugs Reached
  • Jun. 19, 2006 (PDF/15KB)Corporate
    English Court denies its jurisdiction over the Amlodin lawsuit brought by Pfizer
  • Jun. 15, 2006 (PDF/91KB)Products
    Launch of AmBisome 50mg for Intravenous Drip Infusion, a Therapeutic Agent for Systemic Fungal Infection
  • May 31, 2006 (PDF/139KB)Licensing
    Dainippon Sumitomo Pharma and Chelsea Therapeutics International Signed Licensing Agreement for Dops for the treatment of orthostatic hypotension
  • May 11, 2006Finances
    Summary of Consolidated Financial Results For The Year Ended March 31, 2006
  • May 11, 2006 (PDF/18KB)Corporate
    Results of Re-employment Assistance Program
  • Apr. 26, 2006 (PDF/21KB)Corporate
    Notice of Commemorative Dividend
  • Apr. 17, 2006 (PDF/14KB)Licensing
    Dainippon Sumitomo Pharma and Eisai Signed Licensing Agreement for "Gasmotin", a Gastroprokinetic Agent, for Countries in Asia including ASEAN Members
  • Apr. 03, 2006 (PDF/17KB)Corporate
    Integration of US Subsidiaries and Renaming of European subsidiary
  • Mar. 27, 2006 (PDF/17KB)Products
    Pending Expiration of Cooperative Marketing Agreement between Abbott Japan and Dainippon Sumitomo Pharma
  • Feb. 24, 2006 (PDF/18KB)Corporate
    Implementation of Re-employment Assistance Program
  • Feb. 06, 2006 (PDF/603KB)Finances
    Overview of Consolidated Financial Results for the First Nine Months of Fiscal Year 2005 (Unaudited)
  • Feb. 06, 2006 (PDF/51KB)Finances
    Announcement of Revised Results Forecasts
  • Jan. 25, 2006 (PDF/36KB)Corporate
    Pfizer files lawsuit in England regarding licence for Amlodin